Ionis Pharmaceuticals Shares Outstanding 2006-2019 | IONS

Ionis Pharmaceuticals shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Ionis Pharmaceuticals shares outstanding for the quarter ending September 30, 2019 were 0.143B, a 4.41% increase year-over-year.
  • Ionis Pharmaceuticals 2018 shares outstanding were 0.134B, a 6.31% increase from 2017.
  • Ionis Pharmaceuticals 2017 shares outstanding were 0.126B, a 4.27% increase from 2016.
  • Ionis Pharmaceuticals 2016 shares outstanding were 0.121B, a 1.01% increase from 2015.
Ionis Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 134
2017 126
2016 121
2015 120
2014 118
2013 111
2012 101
2011 100
2010 99
2009 98
2008 95
2007 84
2006 74
2005 63
Ionis Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 143
Q2 2019 140
Q1 2019 142
Q4 2018 134
Q3 2018 137
Q2 2018 129
Q1 2018 125
Q4 2017 126
Q3 2017 124
Q2 2017 124
Q1 2017 125
Q4 2016 121
Q3 2016 123
Q2 2016 121
Q1 2016 121
Q4 2015 120
Q3 2015 120
Q2 2015 128
Q1 2015 119
Q4 2014 118
Q3 2014 118
Q2 2014 118
Q1 2014 117
Q4 2013 111
Q3 2013 115
Q2 2013 109
Q1 2013 102
Q4 2012 101
Q3 2012 101
Q2 2012 100
Q1 2012 100
Q4 2011 100
Q3 2011 100
Q2 2011 100
Q1 2011 100
Q4 2010 99
Q3 2010 99
Q2 2010 99
Q1 2010 99
Q4 2009 98
Q3 2009 98
Q2 2009 98
Q1 2009 98
Q4 2008 95
Q3 2008 100
Q2 2008 95
Q1 2008 91
Q4 2007 84
Q3 2007 84
Q2 2007 83
Q1 2007 82
Q4 2006 74
Q3 2006 74
Q2 2006 73
Q1 2006 72
Q4 2005 63
Q3 2005 64
Q2 2005 58
Q1 2005 58
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $8.493B $0.600B
Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.901B 10.10
Zoetis (ZTS) United States $57.261B 34.25
Astellas Pharma (ALPMY) Japan $31.581B 15.77
Eisai (ESALY) Japan $20.389B 39.31
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $15.446B 21.08
Grifols, S.A (GRFS) Spain $15.250B 19.46
Neurocrine Biosciences (NBIX) United States $10.476B 494.57
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.886B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.069B 10.31
Sage Therapeutics (SAGE) United States $7.865B 0.00
Catalent (CTLT) United States $7.542B 30.68
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.203B 18.70
Arrowhead Pharmaceuticals (ARWR) United States $4.652B 106.65
United Therapeutics (UTHR) United States $4.099B 0.00
Nektar Therapeutics (NKTR) United States $3.539B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.503B 12.80
FibroGen (FGEN) United States $3.304B 97.10
Evotec AG (EVTCY) Germany $3.079B 50.38
PTC Therapeutics (PTCT) United States $2.643B 0.00
Tilray (TLRY) Canada $2.249B 0.00
Portola Pharmaceuticals (PTLA) United States $2.227B 0.00
Heron Therapeutics (HRTX) United States $2.198B 0.00
Xencor (XNCR) United States $2.180B 66.26
Zogenix (ZGNX) United States $2.034B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.874B 59.75
Pacira Pharmaceuticals (PCRX) United States $1.839B 54.42
USANA Health Sciences (USNA) United States $1.540B 16.43
Corcept Therapeutics (CORT) United States $1.482B 18.01
Enanta Pharmaceuticals (ENTA) United States $1.250B 28.61
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Radius Health (RDUS) United States $1.081B 0.00
Endo (ENDP) Ireland $1.032B 1.90
ArQule (ARQL) United States $1.026B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.016B 0.00
Karyopharm Therapeutics (KPTI) United States $1.011B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.977B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.909B 6.20
Aerie Pharmaceuticals (AERI) United States $0.852B 0.00
TherapeuticsMD (TXMD) United States $0.719B 0.00
Collegium Pharmaceutical (COLL) United States $0.644B 0.00
Flexion Therapeutics (FLXN) United States $0.643B 0.00
Translate Bio (TBIO) United States $0.643B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.587B 0.00
Organogenesis Holdings (ORGO) United States $0.575B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ImmunoGen (IMGN) United States $0.490B 0.00
ChemoCentryx (CCXI) United States $0.485B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.468B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Dermira (DERM) United States $0.451B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.448B 54.38
Akebia Therapeutics (AKBA) United States $0.412B 0.00
Siga Technologies (SIGA) United States $0.410B 9.37
Ardelyx (ARDX) United States $0.403B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.396B 17.09
Recro Pharma (REPH) United States $0.396B 0.00
OptiNose (OPTN) United States $0.391B 0.00
Harpoon Therapeutics (HARP) United States $0.378B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.375B 0.00
Molecular Templates (MTEM) United States $0.373B 0.00
Indivior (INVVY) United States $0.367B 1.33
Lannett Co Inc (LCI) United States $0.357B 4.15
DURECT (DRRX) United States $0.342B 0.00
Innate Pharma SA (IPHYF) France $0.338B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.332B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.308B 0.00
Rafael Holdings (RFL) United States $0.289B 0.00
GlycoMimetics (GLYC) United States $0.231B 0.00
KalVista Pharmaceuticals (KALV) United States $0.229B 0.00
Calithera Biosciences (CALA) United States $0.226B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.217B 0.00
Xeris Pharmaceuticals (XERS) United States $0.209B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.203B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.190B 0.00
Nature's Sunshine Products (NATR) United States $0.187B 32.20
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Jounce Therapeutics (JNCE) United States $0.159B 2.12
Aquestive Therapeutics (AQST) United States $0.155B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.153B 0.00
CV Sciences (CVSI) United States $0.144B 0.00
Ocular Therapeutix (OCUL) United States $0.142B 0.00
CannTrust Holdings (CTST) Canada $0.135B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.132B 0.00
MEI Pharma (MEIP) United States $0.132B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
Redhill Biopharma (RDHL) Israel $0.126B 0.00
IMV INC (IMV) Canada $0.119B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.093B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.088B 0.00
Majesco Entertainment (PTE) United States $0.084B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.073B 21.77
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Capnia (SLNO) United States $0.066B 0.00
Aclaris Therapeutics (ACRS) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.064B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Pharmaxis (PXSLY) Australia $0.061B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.060B 0.00
Generex Biotechnology (GNBT) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.058B 0.00
Natural Alternatives (NAII) United States $0.057B 14.21
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Novan (NOVN) United States $0.053B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
IsoRay (ISR) United States $0.028B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Melinta Therapeutics (MLNT) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Vical (BBI) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
VAXART, INC (VXRT) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Onconova Therapeutics (ONTX) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00